<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39430559</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2167-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19.</ArticleTitle><Pagination><StartPage>e18330</StartPage><MedlinePgn>e18330</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18330</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.18330</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There exist serious cardiovascular complications subsequent to SARS-Cov2 infection (COVID-19); however, the association between COVID-19 and atrial fibrillation (AF) remains to be elucidated. We aimed to assess the prevalence of AF among COVID-19 patients and its associated risk of death.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The present systematic review was performed in accordance with the PRISMA guidelines. The protocol was registered with CRD42022306523. A comprehensive literature search was performed across PubMed, Embase, and Cochrane databases to identify studies reporting on the prevalence of pre-existing or new-onset fibrillation (AF), and/or the associated clinical outcomes in patients with COVID-19 from January 2020 to December 2023. The random-effect model was used to estimate the prevalence of AF and its related mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 80 studies, including 39,062,868 COVID-19 patients, were identified in the present investigation. The prevalence rates of pre-existing AF or new-onset AF were 10.5% (95% CI [9.3-11.7%]) or 10.3% (95% CI [6.2-14.5%]), respectively. Subgroup analysis revealed a two fold higher incidence of AF in older patients (≥65 years) compared to younger patients (&lt;65 years) (14.4% <i>vs</i>. 6.4%). The highest rate of AF was observed in Europeans (10.7%, 95% CI [10.2-11.2%]), followed by Northern Americans (10.0%, 95% CI [8.2-11.7%]), while Asians demonstrated a lower prevalence (2.7%, 95% CI [2.2-3.3%]). Notably, severe COVID-19 patients displayed a significantly elevated prevalence of AF at 14.l% (95% CI [13.3-14.9%]), which was approximately 2.5-fold higher than that in non-severe patients (5.2%, 95% CI [4.8-5.5%]). Both pre-existing (HR: 1.83, 95% CI [1.49-2.17]) and new-onset AF (HR: 3.47, 95% CI [2.26-5.33]) were associated with an increased mortality risk among COVID-19 patients. Furthermore, the effect on mortality risk was more significant in Asians (HR: 5.33, 95% CI [1.62-9.04]), compared to Europeans (HR: 1.68, 95% CI [1.24-2.13]) and North Americans (HR: 2.01, 95% CI [1.18-2.83]).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study comprehensively investigated the association between AF and COVID-19 in a real-world setting. Notably, a high prevalence of AF was observed among older individuals, severe COVID-19 patients, and in Europe and Northern America. Moreover, co-existing AF was found to be associated with an increased risk for mortality. Further investigations are warranted to improve the management and outcomes of COVID-19 patients with AF.</AbstractText><CopyrightInformation>© 2024 Shen et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Nan-Nan</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jia-Liang</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin-Wen</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yong-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xue-Fang</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, Affiliated Hospital of Shaoxing University, Shao Xing, Zhejiang Province, Shaoxing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39430559</ArticleId><ArticleId IdType="pmc">PMC11490229</ArticleId><ArticleId IdType="doi">10.7717/peerj.18330</ArticleId><ArticleId IdType="pii">18330</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. The New England Journal of Medicine. 2020;383(2):120–128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry MC, Bois MC, Lin PT, Maleszewski JJ, Stone JR. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. European Heart Journal. 2020;41(39):3827–3835. doi: 10.1093/eurheartj/ehaa664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe COVID-19. The New England Journal of Medicine. 2020;383(25):2451–2460. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangemi R, Calvieri C, Falcone M, Bucci T, Bertazzoni G, Scarpellini MG, Barillà F, Taliani G, Violi F, Group SS. Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. The American Journal of Cardiology. 2015;116(4):647–651. doi: 10.1016/j.amjcard.2015.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.05.028</ArticleId><ArticleId IdType="pubmed">26089009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MY, Xiao FP, Kuai L, Zhou HB, Jia ZQ, Liu M, He H, Hong M. Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: a systematic review and meta-analysis. The American Journal of Emergency Medicine. 2021;50:661–669. doi: 10.1016/j.ajem.2021.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.09.050</ArticleId><ArticleId IdType="pmc">PMC8483996</ArticleId><ArticleId IdType="pubmed">34879483</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon CM, Barrios JG, Chiles JW, McElwee SK, Russell DW, Maddox WR, Kay GN. Atrial arrhythmias in COVID-19 patients. JACC. Clinical Electrophysiology. 2020;6(9):1189–1190. doi: 10.1016/j.jacep.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7253953</ArticleId><ArticleId IdType="pubmed">32972558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cota GF, de Sousa MR, Fereguetti TO, Rabello A. Efficacy of anti-leishmania therapy in visceral leishmaniasis among hiv infected patients: a systematic review with indirect comparison. PLOS Neglected Tropical Diseases. 2013;7(5):e2195. doi: 10.1371/journal.pntd.0002195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002195</ArticleId><ArticleId IdType="pmc">PMC3642227</ArticleId><ArticleId IdType="pubmed">23658850</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried JA, Ramasubbu K, Bhatt R, Topkara VK, Clerkin KJ, Horn E, Rabbani L, Brodie D, Jain SS, Kirtane AJ, Masoumi A, Takeda K, Kumaraiah D, Burkhoff D, Leon M, Schwartz A, Uriel N, Sayer G. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930–1936. doi: 10.1161/CIRCULATIONAHA.120.047164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047164</ArticleId><ArticleId IdType="pmc">PMC7314498</ArticleId><ArticleId IdType="pubmed">32243205</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli S, Trevisan C, Del Signore S, Pelagalli G, Volpato S, Gareri P, Mossello E, Malara A, Monzani F, Coin A, Bellelli G, Zia G, Antonelli Incalzi R. COVID-19 and atrial fibrillation in older patients: does oral anticoagulant therapy provide a survival benefit?-an insight from the geroCOVID registry. Thrombosis and Haemostasis. 2021;122:105–112. doi: 10.1055/a-1503-3875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1503-3875</ArticleId><ArticleId IdType="pubmed">33962480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundlund A, Olesen JB, Butt JH, Christensen MA, Gislason GH, Torp-Pedersen C, Kober L, Kumler T, Fosbol EL. One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study. European Heart Journal. 2020;41(10):1112–1119. doi: 10.1093/eurheartj/ehz873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz873</ArticleId><ArticleId IdType="pubmed">31848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, Group ESCSD 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the esc. European Heart Journal. 2021;42:373–498. doi: 10.1093/eurheartj/ehaa612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, Investigators SR. Age and multimorbidity predict death among COVID-19 patients: results of the sars-ras study of the italian society of hypertension. Hypertension. 2020;76(2):366–372. doi: 10.1161/HYPERTENSIONAHA.120.15324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15324</ArticleId><ArticleId IdType="pubmed">32564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124(20):2264–2274. doi: 10.1161/CIRCULATIONAHA.111.019893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.019893</ArticleId><ArticleId IdType="pubmed">22083148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. Journal of Cardiovascular Electrophysiology. 2020;31(5):1003–1008. doi: 10.1111/jce.14479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14479</ArticleId><ArticleId IdType="pmc">PMC7262150</ArticleId><ArticleId IdType="pubmed">32270559</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Shao W, Zhang J, Ma J, Huang S, Yu P, Zhu W, Liu X. Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2021;8:720129. doi: 10.3389/fcvm.2021.720129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.720129</ArticleId><ArticleId IdType="pmc">PMC8548384</ArticleId><ArticleId IdType="pubmed">34722658</ArticleId></ArticleIdList></Reference><Reference><Citation>Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, Smits PC, Tieleman RG, van der Harst P, van Gilst WH, Asselbergs FW, for the CAPACITY-COVID collaborative consortium Cardiac complications in patients hospitalised with COVID-19. European Heart Journal. Acute Cardiovascular Care. 2020;9(8):817–823. doi: 10.1177/2048872620974605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872620974605</ArticleId><ArticleId IdType="pmc">PMC7734244</ArticleId><ArticleId IdType="pubmed">33222494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020;508(10223):254–266. doi: 10.1016/j.cca.2020.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.05.044</ArticleId><ArticleId IdType="pmc">PMC7256510</ArticleId><ArticleId IdType="pubmed">32474009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mair FS, Foster HM, Nicholl BI. Multimorbidity and the COVID-19 pandemic—an urgent call to action. Journal of Comorbidity. 2020;10:2235042X20961676. doi: 10.1177/2235042X20961676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2235042X20961676</ArticleId><ArticleId IdType="pmc">PMC7573706</ArticleId><ArticleId IdType="pubmed">33117721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew T, John SK, Sarma G, Nadig R, Kumar RS, Murgod U, Mahadevappa M, Javali M, Acharya PT, Hosurkar G, Krishnan P, Kamath V, Badachi S, Souza DD, Iyer RB, Nagarajaiah RK, Anand B, Kumar S, Kodapala S, Shivde S, Avati A, Baddala R, Potharlanka PB, Pavuluri S, Varidireddy A, Awatare P, Shobha N, Renukaradhya U, Kumar SP, Ramachandran J, Arumugam R, Deepalam S, Kumar S, Huded V. COVID-19-related strokes are associated with increased mortality and morbidity: a multicenter comparative study from bengaluru, south india. International Journal of Stroke: Official Journal of the International Stroke Society. 2021;16(4):429–436. doi: 10.1177/1747493020968236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020968236</ArticleId><ArticleId IdType="pmc">PMC7723737</ArticleId><ArticleId IdType="pubmed">33034546</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney CA, Fattah C, Loughrey CM, Milligan G, Nicklin SA. Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. Clinical Science. 2014;126(12):815–827. doi: 10.1042/CS20130436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20130436</ArticleId><ArticleId IdType="pubmed">24593683</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Annals of Internal Medicine. 2009;151:264–269. doi: 10.7326/0003-4819-151-4-200908180-00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountantonakis SE, Saleh M, Fishbein J, Gandomi A, Lesser M, Chelico J, Gabriels J, Qiu M, Epstein LM, Northwell COVID-19 Research Consortium Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with sars-cov-2 infection. Heart Rhythm. 2021;18(4):501–507. doi: 10.1016/j.hrthm.2021.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.01.018</ArticleId><ArticleId IdType="pmc">PMC7825902</ArticleId><ArticleId IdType="pubmed">33493650</ArticleId></ArticleIdList></Reference><Reference><Citation>Özdemir İH, Özlek B, Çetin N. Permanent atrial fibrillation portends poor outcomes in hospitalized patients with COVID-19: a retrospective observational study. Methodist DeBakey Cardiovascular Journal. 2021;65:113–120. doi: 10.1016/j.jelectrocard.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC7869683</ArticleId><ArticleId IdType="pubmed">33601308</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris S, Inciardi RM, Lombardi CM, Tomasoni D, Ameri P, Carubelli V, Agostoni P, Canale C, Carugo S, Danzi G, Di Pasquale M, Sarullo F, La Rovere MT, Mortara A, Piepoli M, Porto I, Sinagra G, Volterrani M, Gnecchi M, Leonardi S, Merlo M, Iorio A, Giovinazzo S, Bellasi A, Zaccone G, Camporotondo R, Catagnano F, Dalla Vecchia L, MacCagni G, Mapelli M, Margonato D, Monzo L, Nuzzi V, Pozzi A, Provenzale G, Specchia C, Tedino C, Guazzi M, Senni M, Metra M. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the cardio-COVID-Italy multicentre study. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology. 2021;23(10):1603–1611. doi: 10.1093/europace/euab146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euab146</ArticleId><ArticleId IdType="pmc">PMC8344555</ArticleId><ArticleId IdType="pubmed">34297833</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. American Journal of Respiratory and Critical Care Medicine. 2020;202(5):690–699. doi: 10.1164/rccm.202004-1412OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1412OC</ArticleId><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelps M, Christensen DM, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, Køber L, Kragholm K, Andersson C, Biering-Sørensen T, Christensen HC, Andersen MP, Gislason G. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. European Heart Journal—Quality of Care and Clinical Outcomes. 2021;7(2):172–180. doi: 10.1093/ehjqcco/qcaa081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa081</ArticleId><ArticleId IdType="pmc">PMC7665490</ArticleId><ArticleId IdType="pubmed">33107909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rav-Acha M, Orlev A, Itzhaki I, Zimmerman SF, Fteiha B, Bohm D, Kurd R, Samuel TY, Asher E, Helviz Y, Glikson M, Michowitz Y. Cardiac arrhythmias amongst hospitalised coronavirus 2019 (COVID-19) patients: prevalence, characterisation, and clinical algorithm to classify arrhythmic risk. International Journal of Clinical Practice. 2021;75(4):e13788. doi: 10.1111/ijcp.13788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13788</ArticleId><ArticleId IdType="pubmed">33128270</ArticleId></ArticleIdList></Reference><Reference><Citation>Romiti GF. Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 2021;10(11):2490. doi: 10.3390/jcm10112490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112490</ArticleId><ArticleId IdType="pmc">PMC8200114</ArticleId><ArticleId IdType="pubmed">34199857</ArticleId></ArticleIdList></Reference><Reference><Citation>Romiti GF, Corica B, Lip GYH, Proietti M. Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis. Journal of Clinical Medicine. 2021;10(11):2490. doi: 10.3390/jcm10112490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112490</ArticleId><ArticleId IdType="pmc">PMC8200114</ArticleId><ArticleId IdType="pubmed">34199857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz AP, Tahoces LS, Pérez RO, Ferrer EG, Recalde ÁS, Gómez JLZ. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiology Journal. 2021;28(1):34–40. doi: 10.5603/CJ.a2020.0145.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2020.0145</ArticleId><ArticleId IdType="pmc">PMC8105065</ArticleId><ArticleId IdType="pubmed">33140386</ArticleId></ArticleIdList></Reference><Reference><Citation>Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020;24(9393):91–98. doi: 10.1016/j.jare.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7113610</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId></ArticleIdList></Reference><Reference><Citation>South AM, Diz DI, Chappell MC. COVID-19, ace2, and the cardiovascular consequences. American Journal of Physiology. Heart and Circulatory Physiology. 2020;318(5):H1084–H1090. doi: 10.1152/ajpheart.00217.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00217.2020</ArticleId><ArticleId IdType="pmc">PMC7191628</ArticleId><ArticleId IdType="pubmed">32228252</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinoni EG, Mennuni M, Rognoni A, Grisafi L, Colombo C, Lio V, Renda G, Foglietta M, Petrilli I, D’Ardes D, Sainaghi PP, Aimaretti G, Bellan M, Castello L, Avanzi GC, Corte FD, Krengli M, Pirisi M, Malerba M, Capponi A, Gallina S, Pierdomenico SD, Cipollone F, Patti G, Teamdagger CUC. Contribution of atrial fibrillation to in-hospital mortality in patients with COVID-19. Circulation. Arrhythmia and Electrophysiology. 2021;14(2):e009375. doi: 10.1161/CIRCEP.120.009375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.120.009375</ArticleId><ArticleId IdType="pmc">PMC7892203</ArticleId><ArticleId IdType="pubmed">33591815</ArticleId></ArticleIdList></Reference><Reference><Citation>Terlecki M, Wojciechowska W, Klocek M, Olszanecka A, Stolarz-Skrzypek K, Grodzicki T, Małecki M, Katra B, Garlicki A, Bociąga-Jasik M, Sładek K, Matyja A, Wordliczek J, Słowik A, Mach T, Krzanowska K, Krzanowski M, Stręk P, Chłosta P, Hydzik P, Korkosz M, Popiela T, Pilecki M, Gądek A, Rajzer M. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in poland. NPJ Digital Medicine. 2021;79:773–780. doi: 10.33963/KP.15990.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.15990</ArticleId><ArticleId IdType="pubmed">33926173</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorici MA, Walls AC, Lang Y, Wang C, Li Z, Koerhuis D, Boons GJ, Bosch BJ, Rey FA, de Groot RJ, Veesler D. Structural basis for human coronavirus attachment to sialic acid receptors. Nature Structural &amp; Molecular Biology. 2019;26(6):481–489. doi: 10.1038/s41594-019-0233-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0233-y</ArticleId><ArticleId IdType="pmc">PMC6554059</ArticleId><ArticleId IdType="pubmed">31160783</ArticleId></ArticleIdList></Reference><Reference><Citation>Velilla-Alonso G, García-Pastor A, Rodríguez-López Á, Gómez-Roldós A, Sánchez-Soblechero A, Amaya-Pascasio L, Díaz-Otero F, Fernández-Bullido Y, Iglesias-Mohedano AM, Vázquez-Alén P, Vales-Montero M, Gil-Núñez AC. Acute stroke care during the COVID-19 pandemic: reduction in the number of admissions of elderly patients and increase in prehospital delays. Cerebrovascular Diseases. 2021;50(3):310–316. doi: 10.1159/000514140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514140</ArticleId><ArticleId IdType="pmc">PMC8089401</ArticleId><ArticleId IdType="pubmed">33730715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. The Journal of The American Medical Association. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. International Journal of Antimicrobial Agents. 2020;55(5):105955. doi: 10.1016/j.ijantimicag.2020.105955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105955</ArticleId><ArticleId IdType="pmc">PMC7138178</ArticleId><ArticleId IdType="pubmed">32234468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Lee S, Wang X, Li Y, Wu WKK, Liu T, Cao Z, Zeng DD, Leung KSK. Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong. NPJ Digital Medicine. 2021;4(1):66–70. doi: 10.1038/s41746-021-00433-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00433-4</ArticleId><ArticleId IdType="pmc">PMC8032826</ArticleId><ArticleId IdType="pubmed">33833388</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Bilato C, Zanon F, Zuliani G, Roncon L. Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 patients. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing. 2021;62(2):231–238. doi: 10.1007/s10840-021-00992-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-00992-2</ArticleId><ArticleId IdType="pmc">PMC8046494</ArticleId><ArticleId IdType="pubmed">33855639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>